Latest filing published 29 May 2024 for HAEMONETICS CORP, €398k.
Filing timeline
BuySaleInsider track record
Josep Llorens: trading record in brief
Josep Llorens is a declared insider of Haemonetics Corp (chief executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 4 September 2018 to 28 May 2024, the count stands at 33 filings.
Every open-market trade on record is a sale: 14 sales worth €958k. The rest of the record consists of 16 share grants and 3 option exercises. In 2024 alone, the filings show no purchases and 3 sales.
On 29 May 2024 came the latest disclosure, a share grant for €398k in Haemonetics Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Josep Llorens
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,510 shares@ US$95.7320.4% of flowCommon StockSEC:0001127602-24-016813:1
- 14,140 shares0Common StockSEC:0001127602-24-016813:0
- 6,267 sharesCommon StockSEC:0001127602-24-016169:2
- 320 shares@ US$95.731.4% of flowCommon StockSEC:0001127602-24-016169:1
- 987 shares@ US$95.084.4% of flowCommon StockSEC:0001127602-24-016169:3
- 822 shares@ US$94.8212.8% of flowCommon StockSEC:0001127602-24-016169:0
- 263 shares@ US$94.801.2% of flowCommon StockSEC:0001127602-24-015868:1
- 770 shares@ US$96.143.5% of flowCommon StockSEC:0001127602-24-015868:2
- 258 shares@ US$96.494.1% of flowCommon StockSEC:0001127602-24-015868:0
- 2,537 shares@ US$57.606.7% of flowCommon StockSEC:0001127602-23-021080:1
- 4,928 shares@ US$90.0020.3% of flowCommon StockSEC:0001127602-23-021080:2
- 2,391 shares@ US$56.5721.4% of flowCommon StockSEC:0001127602-23-021080:0
- 1,423 shares@ US$83.3419.6% of flowCommon StockSEC:0001127602-23-016313:0
- 319 shares@ US$89.211.3% of flowCommon StockSEC:0001127602-23-015937:1
- 3,084 sharesCommon StockSEC:0001127602-23-015937:0
- 113 shares@ US$88.161.6% of flowCommon StockSEC:0001127602-23-015738:0
- 2,391 shares@ US$90.0010.2% of flowCommon StockSEC:0001127602-23-002187:1
- 2,391 shares@ US$56.5722.2% of flowCommon StockSEC:0001127602-23-002187:0
- 101 shares@ US$73.781.3% of flowCommon StockSEC:0001127602-22-022153:0
- 1,418 shares@ US$59.1014.1% of flowCommon StockSEC:0001127602-22-015369:0
- 4,340 sharesCommon StockSEC:0001127602-22-014988:1
- 107 shares@ US$56.101.0% of flowCommon StockSEC:0001127602-22-014988:0
- 100 shares@ US$64.611.0% of flowCommon StockSEC:0000899243-21-035451:0
- 7,070 sharesCommon StockSEC:0001127602-21-017681:1
- 125 shares@ US$55.190.9% of flowCommon StockSEC:0001127602-21-017681:2
25 of 33 declarations
